Research output

Differences in clinical condition and genotype at time of diagnosis of cystic fibrosis by newborn screening or by symptoms

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

  • Vernooij-van Langen, A. M. M.
  • Gerzon, F. L. G. R.
  • Loeber, J. G.
  • Dompeling, E.

  • Dankert-Roelse, J. E.

Associated organisations

Abstract

Background: Early diagnosis through newborn screening (NBS) and early treatment of cystic fibrosis (CF) do lead to better prognosis. In the Netherlands, the median age for a clinical diagnosis is six months, and after newborn screening this is 30 days. It is unknown if being diagnosed at the age of six months or before two months leads to a clinically relevant difference of the clinical condition at the time of diagnosis.

Aim: The aim of this study is to assess the differences in clinical parameters at diagnosis between children with CF identified by newborn screening (NBS) or by clinical diagnosis (CD) in the Netherlands.

Methods: From July 1st, 2007 to January 1st, 2012 all newly diagnosed CF patients were reported to the Dutch Paediatric Surveillance Unit (DPSU). All paediatricians received a questionnaire to collect data on mutations and clinical condition at diagnosis. Non-classical CF was excluded from the analysis on clinical condition.

Results: 204 new CF diagnoses were reported to the DPSU, 33 were reported twice and three had no CF after further testing. 127 questionnaires were returned (76%); 85 children were diagnosed because of clinical symptoms, 40 after NBS and two because of a positive family history. The median age at diagnosis was 34 weeks for a clinical diagnosis and 3 weeks after NBS. Non-classical CF was more prevalent in the NBS group (6 clinical, 14 NBS), mostly F508de1/R117H7T (12). Compared to the NBS group, significantly more patients in the CD group showed failure to thrive, respiratory symptoms, and hospitalizations. 62% of the CD group showed abnormal signs at physical examination compared to 4% of the NBS group.

Conclusion: At the time of diagnosis infants detected after NBS are in a significantly better condition than after a clinical diagnosis. Growth retardation is already seen when after NBS the diagnosis is confirmed, but NBS leads to a diagnosis before respiratory symptoms have developed. (C) 2014 Elsevier Inc. All rights reserved.

    Research areas

  • Newborn screening, Cystic fibrosis, Genotype, Symptoms, Clinical condition, PSEUDOMONAS-AERUGINOSA, IMPROVED SURVIVAL, OUTCOMES, CHILDREN, INFANTS, DISEASE, COHORT
View graph of relations

Details

Original languageEnglish
Pages (from-to)100-104
Number of pages5
JournalMolecular Genetics and Metabolism
Volume113
Issue number1-2
DOIs
Publication statusPublished - 1 Jan 2014